Serotype-Switch Variant of Multidrug-Resistant Streptococcus pneumoniae Sequence Type 271

por Scherer, Erin M., Beall, Bernard, Metcalf, Benjamin
Publicado 2021

Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV

por Losada, Cecilia, Samaha, Hady, Scherer, Erin M., Kazzi, Bahaa, Khalil, Lana, Ofotokun, Ighovwerha, Rouphael, Nadine
Publicado 2023

Characteristics of Memory B Cells Elicited by a Highly Efficacious HPV Vaccine in Subjects with No Pre-existing Immunity

por Scherer, Erin M., Smith, Robin A., Simonich, Cassandra A., Niyonzima, Nixon, Carter, Joseph J., Galloway, Denise A.
Publicado 2014

Analysis of Memory B-Cell Responses Reveals Suboptimal Dosing Schedule of a Licensed Vaccine

por Scherer, Erin M, Smith, Robin A, Carter, Joseph J, Wipf, Gregory C, Gallego, Daniel F, Stern, Michael, Wald, Anna, Galloway, Denise A
Publicado 2018

Sterile inflammation induced by Carbopol elicits robust adaptive immune responses in the absence of pathogen-associated molecular patterns

por Gartlan, Kate H., Krashias, George, Wegmann, Frank, Hillson, William R., Scherer, Erin M., Greenberg, Philip D., Eisenbarth, Stephanie C., Moghaddam, Amin E., Sattentau, Quentin J.
Publicado 2016

A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects

por Scherer, Erin M., Smith, Robin A., Gallego, Daniel F., Carter, Joseph J., Wipf, Gregory C., Hoyos, Manuela, Stern, Michael, Thurston, Tate, Trinklein, Nathan D., Wald, Anna, Galloway, Denise A.
Publicado 2016

Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies

por Whaley, Rachael E., Ameny, Sarah, Arkatkar, Tanvi, Seese, Aaron, Wall, Abigail, Khan, Iram, Carter, Joseph J., Scherer, Erin M., Rawlings, David J., Galloway, Denise A., McElrath, M. Juliana, Cohen, Kristen W., McGuire, Andrew T.
Publicado 2021

Polyethyleneimine is a potent mucosal adjuvant for glycoproteins with innate and adaptive immune activating properties

por Wegmann, Frank, Gartlan, Kate H, Harandi, Ali M, Brinckmann, Sarah A, Coccia, Margherita, Hillson, William R, Kok, Wai Ling, Cole, Suzanne, Ho, Ling-Pei, Lambe, Teresa, Puthia, Manoj, Svanborg, Catharina, Scherer, Erin M, Krashias, George, Williams, Adam, Blattman, Joseph N, Greenberg, Philip D, Flavell, Richard A, Moghaddam, Amin E, Sheppard, Neil C, Sattentau, Quentin J
Publicado 2012

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

por Premkumar, Lakshmanane, Segovia-Chumbez, Bruno, Jadi, Ramesh, Martinez, David R., Raut, Rajendra, Markmann, Alena, Cornaby, Caleb, Bartelt, Luther, Weiss, Susan, Park, Yara, Edwards, Caitlin E., Weimer, Eric, Scherer, Erin M., Rouphael, Nadine, Edupuganti, Srilatha, Weiskopf, Daniela, Tse, Longping V., Hou, Yixuan J., Margolis, David, Sette, Alessandro, Collins, Matthew H., Schmitz, John, Baric, Ralph S., de Silva, Aravinda M.
Publicado 2020

SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients

por Scherer, Erin M., Babiker, Ahmed, Adelman, Max W., Allman, Brent, Key, Autum, Kleinhenz, Jennifer M., Langsjoen, Rose M., Nguyen, Phuong-Vi, Onyechi, Ivy, Sherman, Jacob D., Simon, Trevor W., Soloff, Hannah, Tarabay, Jessica, Varkey, Jay, Webster, Andrew S., Weiskopf, Daniela, Weissman, Daniel B., Xu, Yongxian, Waggoner, Jesse J., Koelle, Katia, Rouphael, Nadine, Pouch, Stephanie M., Piantadosi, Anne
Publicado 2022

Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design

por Jardine, Joseph G., Sok, Devin, Julien, Jean-Philippe, Briney, Bryan, Sarkar, Anita, Liang, Chi-Hui, Scherer, Erin M., Henry Dunand, Carole J., Adachi, Yumiko, Diwanji, Devan, Hsueh, Jessica, Jones, Meaghan, Kalyuzhniy, Oleksandr, Kubitz, Michael, Spencer, Skye, Pauthner, Matthias, Saye-Francisco, Karen L., Sesterhenn, Fabian, Wilson, Patrick C., Galloway, Denise A., Stanfield, Robyn L., Wilson, Ian A., Burton, Dennis R., Schief, William R.
Publicado 2016

Application of SARS-CoV-2 Serology to Address Public Health Priorities

por Sherman, Amy C., Smith, Teresa, Zhu, Yerun, Taibl, Kaitlin, Howard-Anderson, Jessica, Landay, Taylor, Pisanic, Nora, Kleinhenz, Jennifer, Simon, Trevor W., Espinoza, Daniel, Edupuganti, Neena, Hammond, Skyler, Rouphael, Nadine, Shen, Huifeng, Fairley, Jessica K., Edupuganti, Srilatha, Cardona-Ospina, Jaime A., Rodriguez-Morales, Alfonso J., Premkumar, Lakshmanane, Wrammert, Jens, Tarleton, Rick, Fridkin, Scott, Heaney, Christopher D., Scherer, Erin M., Collins, Matthew H.
Publicado 2021

Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

por Suthar, Mehul S., Zimmerman, Matthew G., Kauffman, Robert C., Mantus, Grace, Linderman, Susanne L., Hudson, William H., Vanderheiden, Abigail, Nyhoff, Lindsay, Davis, Carl W., Adekunle, Oluwaseyi, Affer, Maurizio, Sherman, Melanie, Reynolds, Stacian, Verkerke, Hans P., Alter, David N., Guarner, Jeannette, Bryksin, Janetta, Horwath, Michael C., Arthur, Connie M., Saakadze, Natia, Smith, Geoffrey H., Edupuganti, Srilatha, Scherer, Erin M., Hellmeister, Kieffer, Cheng, Andrew, Morales, Juliet A., Neish, Andrew S., Stowell, Sean R., Frank, Filipp, Ortlund, Eric, Anderson, Evan J., Menachery, Vineet D., Rouphael, Nadine, Mehta, Aneesh K., Stephens, David S., Ahmed, Rafi, Roback, John D., Wrammert, Jens
Publicado 2020